Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting-Reference-Cited by-同舟云学术

Efficacy and safety of adalimumab in psoriatic patients previously treated with etanercept in a real-world setting

Published:2014-07 Issue:3 Volume:26 Page:217-222
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Fonseca Eduardo,Iglesias Raquel,Paradela Sabela,Fernández-Torres Rosa M.,Elberdín Laida

Publisher

Informa UK Limited

Subject

Dermatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference36 articles.

1. Psoriasis and its management

2. Pathogenesis and clinical features of psoriasis

3. A systematic review of treatments for severe psoriasis.

4. The cytokine and chemokine network in psoriasis

5. Fonseca E, Paradela S, Rodríguez Lozano J, Fernández Torres RM. Terapias biológicas para la psoriasis. 2nd ed. Madrid: Fundación do Complexo Hospitalario Universitario A Coruña. Chapter 6, Guías para el tratamiento de la psoriasis en placas moderada-grave con terapias biológicas, 2009. p. 117–36

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis;Frontiers in Medicine;2022-12-08

2. Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks;International Journal of Environmental Research and Public Health;2022-06-02

3. Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago;Dermatology and Therapy;2022-02-28

4. Ustekinumab treatment for moderate to severe psoriasis. Eight-year real-world follow-up of 61 cases in a tertiary level hospital;Journal of Dermatological Treatment;2019-06-28

5. Biologics switch in psoriasis;Immunotherapy;2019-04